Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim F Greten

Showing results (51-60 of 222) with videos related to

Pageof 23
Sort By:
Gut|February 11, 2015
Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approachesTim F Greten, Xin W Wang, Firouzeh Korangy
International Immunopharmacology|January 18, 2011
Myeloid derived suppressor cells in human diseasesTim F Greten, Michael P Manns, Firouzeh Korangy
Journal of Hepatology|October 19, 2006
Immunotherapy of hepatocellular carcinomaTim F Greten, Michael P Manns, Firouzeh Korangy
Reviews on Recent Clinical Trials|May 14, 2008
Immunotherapy of HCCTim F Greten, Michael P Manns, Firouzeh Korangy
Therapeutic Advances in Gastroenterology|November 1, 2018
Current frontline approaches in the management of hepatocellular carcinoma: the evolving role of immunotherapyGagandeep Brar, Tim F Greten, Zachary J Brown
Nature Cancer|February 5, 2022
Microbiome genomics for cancer predictionLorenz Adlung, Eran Elinav, Tim F Greten, et al.
Oncoimmunology|December 18, 2012
Human Th17 cells in patients with cancer: Friends or foe?Tim F Greten, Fei Zhao, Jaba Gamrekelashvili, et al.
Journal of Racial and Ethnic Health Disparities|September 23, 2024
Unveiling Disparities: Analyzing Hispanic Inclusion in Liver Cancer Research Databases in the United StatesGabriela Arroyo Figueroa, Tim F Greten, Cecilia Monge Bonilla
Gut|November 30, 2013
Response to fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: better 5-year survival or artefactual result of research methodology?Tobias Eggert, Katherine McGlynn, Tim F Greten, et al.
Cancer Immunology, Immunotherapy : CII|July 3, 2015
Hepatic myeloid-derived suppressor cells in cancerJosé Medina-Echeverz, Tobias Eggert, Miaojun Han, et al.
Pageof 23

Showing results (51-60 of 222) with videos related to

Sort By:
Pageof 23
Gut|February 11, 2015
Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approachesTim F Greten, Xin W Wang, Firouzeh Korangy
International Immunopharmacology|January 18, 2011
Myeloid derived suppressor cells in human diseasesTim F Greten, Michael P Manns, Firouzeh Korangy
Journal of Hepatology|October 19, 2006
Immunotherapy of hepatocellular carcinomaTim F Greten, Michael P Manns, Firouzeh Korangy
Reviews on Recent Clinical Trials|May 14, 2008
Immunotherapy of HCCTim F Greten, Michael P Manns, Firouzeh Korangy
Therapeutic Advances in Gastroenterology|November 1, 2018
Current frontline approaches in the management of hepatocellular carcinoma: the evolving role of immunotherapyGagandeep Brar, Tim F Greten, Zachary J Brown
Nature Cancer|February 5, 2022
Microbiome genomics for cancer predictionLorenz Adlung, Eran Elinav, Tim F Greten, et al.
Oncoimmunology|December 18, 2012
Human Th17 cells in patients with cancer: Friends or foe?Tim F Greten, Fei Zhao, Jaba Gamrekelashvili, et al.
Journal of Racial and Ethnic Health Disparities|September 23, 2024
Unveiling Disparities: Analyzing Hispanic Inclusion in Liver Cancer Research Databases in the United StatesGabriela Arroyo Figueroa, Tim F Greten, Cecilia Monge Bonilla
Gut|November 30, 2013
Response to fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: better 5-year survival or artefactual result of research methodology?Tobias Eggert, Katherine McGlynn, Tim F Greten, et al.
Cancer Immunology, Immunotherapy : CII|July 3, 2015
Hepatic myeloid-derived suppressor cells in cancerJosé Medina-Echeverz, Tobias Eggert, Miaojun Han, et al.
Pageof 23